Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-25

Clinical Trial Update: Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors [NA]

View source ↗

Summary

A clinical trial is evaluating whether a Mediterranean diet improves signs and symptoms of psoriasis in patients receiving anti-IL-17 or anti-IL-23 inhibitors, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-IL-17 inhibitors
  • Anti-IL-23 inhibitors

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Psoriasis | NA | Status: RECRUITING